Skip to content
Open access

Formulation, optimization and characterization of apremilast-loaded nanosponges for potential topical wound management applications

Jul 2026 · Journal of Applied Pharmaceutical Research · Vol 14, pp. 267-276 · 0 citations

TL;DR

Apremilast-loaded nanosponges demonstrated sustained drug release, excellent stability, and favorable physicochemical characteristics, indicating their potential as an effective topical delivery system for wound management.

Abstract

Background: Topical drug delivery systems provide site-specific therapy with reduced systemic exposure. Nanosponges have emerged as promising carriers owing to their porous structure, enabling improved drug stability, bioavailability, and sustained release. Apremilast, a phosphodiesterase-4 (PDE4) inhibitor with anti-inflammatory activity, has potential for topical wound management when formulated as a controlled-release delivery system. Methods: Apremilast-loaded nanosponges were prepared by the emulsion solvent diffusion method using Ethyl Cellulose (EC) and Polyvinyl Alcohol (PVA). A 3² factorial design was used to optimize the EC: PVA ratio and sonication time. Formulations were evaluated for particle size, entrapment efficiency, zeta potential, in vitro drug release, and surface morphology. Characterization included UV spectroscopy, FTIR, XRD, DSC, and SEM. Drug release kinetics were analyzed using mathematical models. Results: Preformulation studies confirmed drug purity and compatibility with excipients. The optimized formulation (NS8) exhibited a particle size of 213.85 nm, an entrapment efficiency of 82.75%, a zeta potential of −33.3 mV, and a sustained drug release of 95.85% over 24 h. SEM revealed spherical porous nanosponges, while FTIR, XRD, and DSC confirmed drug integrity and formulation stability. Response surface analysis demonstrated significant effects of formulation variables on performance. Drug release followed the Higuchi model (R² = 0.987), and the Korsmeyer–Peppas exponent (n = 0.58) indicated anomalous non-Fickian diffusion. Conclusion: Apremilast-loaded nanosponges demonstrated sustained drug release, excellent stability, and favorable physicochemical characteristics, indicating their potential as an effective topical delivery system for wound management. Further ex vivo, in vivo, and clinical studies are required to confirm therapeutic efficacy and safety.

Read PDF

Similar papers

Open access Aug 2026

Statistical optimization and physicochemical characterization of acitretin-loaded nanostructured lipid carriers for enhanced topical delivery and sustained drug release

Acitretin is a first-line retinoid for the management of psoriasis and other hyperkeratotic skin disorders; however, its therapeutic application is limited by poor aqueous solubility, inadequate skin retention, and dose-dependent systemic adverse effects following oral administration. The objective of the present study...

Abhishek Kumar Gautam, Vikash Gupta · 0 citations
Review Sep 2026

Recent Innovations in Nanoemulsion and Nanoemulgel-Based Topical Drug Delivery Systems: Formulation, Characterization, and Clinical Translation.

The therapeutic application of nanoemulgels in dermatological, anti-inflammatory, antimicrobial, and cosmetic applications is exemplified to clarify improvements in therapeutic efficacy, decreased systemic toxicity, and increased patient acceptability.

M. Zafar, Prevesh Kumar, Diksha et al. · 0 citations
Aug 2026

Formulation and In vitro Characterization of Rosuvastatin Calcium Loaded Chitosan Nanoparticles for Sustained Drug Release

It is suggested that RST-loaded chitosan nanoparticles represent a promising oral nanocarrier system with sustained release characteristics and the potential to improve the oral performance of poorly water-soluble drugs such as rosuvastatin calcium.

M. Sarwer, R. M. Sarfraz, Asif Mahmood et al. · 0 citations
Sep 2026

Formulation and Evaluation of a Lemon Essential Oil-Loaded Nanosponge Hydrogel for Sustained Therapeutic Delivery

The successful incorporation of LEO into a nanosponge-based hydrogel and subsequent formulation as a hydrogel for targeted therapeutic applications are demonstrated and provide preliminary evidence supporting its potential therapeutic application.

Ram Narayanan Ravi, Maanvizhi Saba, A. Gnanamani · 0 citations
Open access Sep 2026

Engineering Teriflunomide Solid Lipid Nanoparticles via Response Surface Methodology: Formulation Optimization and In vitro Performance Evaluation

Objective: Multiple sclerosis is a chronic inflammatory disorder of the central nervous system, commonly managed with Teriflunomide, a poorly water-soluble BCS Class II drug. The present study was designed to develop and optimize Teriflunomide-loaded solid lipid nanoparticles (TFE-SLNs) to improve its solubility and dr...

Praveen Kumar Reddy A., Anjan Kumar, Bharghava Bhushan Rao P. · 0 citations
Open access Sep 2026

Nano Engineered Chitosan-Based Delivery System for Vonoprazan Fumarate for Enhanced Bioavailability: Fabrication and Evaluation

Purpose The main purpose of the present study was to explore chitosan as a polymeric material for the preparation of vonoprazan nanoparticles intended for use as a delivery system for acid-related diseases. Methods Vonoprazan-loaded chitosan nanoparticles were formulated using the ionotropic gelation method and charact...

S. Sajjad, U. Tulain, M. Asim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.